Gilead Sciences GILD NASDAQ:GILD

Broadsoft Expected to Report Strong Quarter; Sprint Bringing Credibility in Mobile

For fourth quarter 2013, BroadSoft should meet or beat consensus estimates. We expect a large chunk of deferred revenue to come off the balance sheet and billings to show significant improvement sequentially in virtually all areas license, subscription, and maintenance on easy comparisons with the exception of professional services, which rebounded sharply in the third…

Read More

Improved Outlook for Solera Drives Another Increase to Guidance

Solera reported relatively in-line fiscal second-quarter results on Wednesday, February 5, and meaningfully increased its guidance for fiscal 2014. Adjusted EPS of $0.64 in the fiscal second quarter were $0.02 higher than our estimate and in line with the consensus. Revenue growth of 14% year-over-year in the quarter (about 6% organically) was in line with…

Read More